REVB — Revelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · revbiosciences.com

1.075USD-1.38%Mkt Cap: 4.21M USDP/E: —Last update: 2026-06-01

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a pro…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap4.21M USD

Enterprise Value-9.07M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-8.91M USD

Revenue/Share—

Last Price1.075 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees8

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.39

PEG—

EV/EBITDA0.90

EV/Revenue—

P/S—

P/B0.33

EPS (TTM)-1.32

EPS (Forward)-2.77

52W Range

0.87502% of range13.80

52W High13.80 USD

52W Low0.8750 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-100.59%

ROA-76.96%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.27M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-128.24%

Net Debt-13.35M USD

Net Debt/EBITDA1.33

Balance Sheet

Debt/Equity0.08

Current Ratio10.02

Quick Ratio9.96

Book Value/Sh3.323 USD

Cash/Share3.611 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:4

Split DateJan 28, 2026

Analyst Consensus

Rating—

Target (Mean)19.25 USD

Target Range16.00 USD – 22.50 USD

# Analysts2

Ownership

Shares Out.3.91M

Float3.44M

Insiders4.79%

Institutions12.78%

Short Interest

Short Ratio0.4d

Short % Float0.92%

Short % Out.0.88%

Shares Short34.51K

Short (prev mo.)22.51K

Technical

SMA 501.127 (-4.6%)

SMA 2003.727 (-71.2%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)55.20K

Avg Vol (10d)38.76K

Technical Indicators

RSI (14)50.1

MACD-0.0181

MACD Signal-0.0323

MACD Hist.+0.0142

BB Upper1.134 USD

BB Middle1.049 USD

BB Lower0.9638 USD

BB Width16.23%

ATR (14)0.0595 USD

Vol Ratio (20d)0.54x